Open AccessHeartWare HVAD: Postoperative issues in our first patient
Author(s) -
Sarvesh Pal Singh,
Sandeep Seth,
Manoj Kumar Sahu,
Balram Airan
Publication year - 2017
Publication title -
journal of the practice of cardiovascular sciences
Language(s) - English
Resource type - Journals
eISSN - 2454-2830
pISSN - 2395-5414
DOI - 10.4103/jpcs.jpcs_64_16
Subject(s) - ventricular assist device , preload , pulsatile flow , cardiology , destination therapy , afterload , medicine , heart failure , ascending aorta , aorta , hemodynamics
Ventricular assist devices (VADs) serve as a bridge to heart transplant or destination therapy in end stage heart failure. HeartWare HVAD is a second generation, non pulsatile, magnetically levitated centrifugal pump, which is preload dependent and afterload sensitive. It has an inlet that is cored into the left ventricular wall and an outflow that is attached to a graft which is sutured into the ascending aorta. The Registry to Evaluate the HeartWare Left Ventricular Assist System (ReVOLVE) registry has reported a 2 year survival of 76% and 5 year survival of 59%. We present our experience of the first HeartWare 2 HVAD implanted at our institute